Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 29 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DR. LEFEVER EN DR. HOEBANX from Holsbeek, company number BE0479273832, closed financial year 2025 with a result of € 128,741 after tax. For that financial year DR. LEFEVER EN DR. HOEBANX recorded a gross margin of € 211,145 and equity of € 848,576. Compared with financial year 2024, the result moved from € 141,212 to € 128,741. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ 848,576
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 128,741
▼ 9% vs 2024
Profit after tax over the fiscal year.
€ 51,276
▲ 37% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 134,742 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 8,653
▼ 44% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1,525
▼ 85% vs 2024
Loans from banks and other lenders, long and short.
€ 927
▼ 92% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,122
▲ 115% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 249,448 | € 208,505 | € 223,434 | € 211,145 | ▼ 6% |
| Profit after taxes | € 154,506 | € 138,108 | € 141,212 | € 128,741 | ▼ 9% |
| Equity | € 1,107,856 | € 850,363 | € 854,577 | € 848,576 | ▼ 1% |
| Total debts | € 72,383 | € 137,497 | € 170,381 | € 204,699 | ▲ 20% |
| Cash | € 21,964 | € 40,816 | € 37,350 | € 51,276 | ▲ 37% |
| Land & buildings | € 602,986 | € 727,155 | € 726,042 | € 767,789 | ▲ 6% |
| Retained profit | € 1,089,256 | € 831,763 | € 835,977 | € 829,976 | ▼ 1% |
| Dividend | € 0 | € 395,601 | € 136,998 | € 134,742 | ▼ 2% |
| Bank debt | € 35,352 | € 23,687 | € 10,487 | € 1,525 | ▼ 85% |
| Balance sheet total | € 1,180,240 | € 987,860 | € 1,024,958 | € 1,053,275 | ▲ 3% |
Key figures of DR. LEFEVER EN DR. HOEBANX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. LEFEVER EN DR. HOEBANX?
What happened at DR. LEFEVER EN DR. HOEBANX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 128,741 (▼ 9% vs 2024). filed late Source: NBB ↗
- New establishment in Holsbeek. KBO
- Start of the company according to the CBE. KBO
- Liesbet Hoebanx became a director. NBB
- Samuel Lefever became a director. NBB
In short
From € 154,506 profit in 2022 to € 128,741 profit in 2025.
Paid € 260,858 in corporate taxes since 2022.
Best year ever: 2022, with € 154,506 profit.
Paid out € 667,341 in dividends to the owners in total.
A new publication or filing at DR. LEFEVER EN DR. HOEBANX? We notify you, reason included.
Follow DR. LEFEVER EN DR. HOEBANXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DR. LEFEVER EN DR. HOEBANX are Liesbet Hoebanx and Samuel Lefever. It owns 20% of Immo penta itself.
Directors
According to the 2025 annual accounts
Liesbet Hoebanx
Director
since 2002
since 2002
Establishments
Establishment units
Physical locations of this company
Kraaikant 28
3221 Holsbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.273.832
- VAT number
- BE 0479.273.832
- Registered office
- Kraaikant 28, 3221 Holsbeek
- Names & denominations
- DR. LEFEVER EN DR. HOEBANX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 January 2003
- Peppol
- Active · Active since 5 Jan 2026
- Activities · NACE
Activiteiten van huisartspraktijken
Overige zakelijke dienstverlening, neg